A type of cell that plays a crucial role in tissue repair after a heart attack may also inadvertently be why cutting-edge cell therapies cause an increased risk of rhythm disorders, according to a new study. Researchers hope the findings could open up new pathways to safe regenerative treatments for people who have suffered a heart attack.
A type of cell that plays a crucial role in tissue repair after a heart attack may also inadvertently be why cutting-edge cell therapies cause an increased risk of rhythm disorders, according to a new study. Researchers hope the findings could open up new pathways to safe regenerative treatments for people who have suffered a heart attack. A type of cell that plays a crucial role in tissue repair after a heart attack may also inadvertently be why cutting-edge cell therapies cause an increased risk of rhythm disorders, according to a new study. Researchers hope the findings could open up new pathways to safe regenerative treatments for people who have suffered a heart attack.